Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2026-01-02 @ 9:16 PM
Study NCT ID:
NCT00255658
Status:
COMPLETED
Last Update Posted:
2015-04-15
First Post:
2005-11-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid Tumors
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
NCI-2012-03164
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None